Company Financials

Recursion Pharmaceuticals, Inc. Financials

United States dollar

business Recursion Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: RXRX

Market Capitalization $2.19 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -2.49
Forward PE -3.42
Price to Sales TTM $48.80
Price to Book MRQ $1.92
Enterprise to Revenue 35.58
Enterprise to EBITDA -2.44

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 22.65%
Operating Margin -3327.58%
Return on Assets TTM -42.04%
Return on Equity TTM -91.07%

Income Statement

Revenue TTM $43,689,000
Revenue per Share TTM $0.11
Quarterly Revenue Growth -80.20%
Gross Profit TTM $-503,448,000
EBITDA $-637,875,968
Net Income to Common TTM $-715,542,976
Diluted EPS TTM $-1.84
Quarterly Earnings Growth YoY -80.89%

Balance Sheet

Total Cash MRQ $659,836,032
Total Cash per Share MRQ $1.27
Total Debt MRQ $
Total Debt to Equity MRQ 7.87
Current Ratio MRQ 4.60
Book Value per Share MRQ $2.13

Cash Flow

Operating Cash Flow TTM $-441,164,992
Levered Free Cash Flow TTM $-227,066,496

RXRX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 491,800,501
Float Shares 504,019,384
Avg 10 Volume 28,609,270
Avg 30 Volume None
Shares Short 153,738,758
Short Ratio 7.31
Short % of Shares 31.29%
% Held by Insiders 3.93%
% Held by Institutions 60.72%

Stock Price Summary

Beta 0.94
Fifty Two Week Low $3.79
Fifty Two Week High $12.36
Fifty Two Week Change -89.29%
Day 50 MA $4.71
Day 200 MA $5.10

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date